Showing results (231-240 of 261) with videos related to

Sort By:
Pageof 27
Clinical and Experimental Rheumatology|May 4, 2017
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC)Massimo Galli, Letizia Oreni, Francesco Saccardo, et al.
Annals of the Rheumatic Diseases|November 3, 2022
2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseasesGeorge E Fragoulis, Elena Nikiphorou, Mrinalini Dey, et al.
ERJ Open Research|March 10, 2022
Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre studyPaola Faverio, Alessia Fumagalli, Sara Conti, et al.
Clinical and Experimental Rheumatology|October 6, 2022
Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for RheumatologyAndreina Manfredi, Giulia Cassone, Raffaella Izzo, et al.
Respiratory Research|March 22, 2022
One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up studyPaola Faverio, Fabrizio Luppi, Paola Rebora, et al.
Clinical and Experimental Rheumatology|August 31, 2023
Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDsLaura Scagnellato, Antonio Collesei, Andrea Doria, et al.
Clinical Rheumatology|September 28, 2022
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC)Luca Quartuccio, Alessandra Bortoluzzi, Carlo Alberto Scirè, et al.
The Lancet. Respiratory Medicine|June 5, 2026
Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment-an expert group consensus statementJoshua J Solomon, Philippe Dieudé, Scott M Matson, et al.
Therapeutic Advances in Musculoskeletal Disease|February 3, 2025
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA RegistryGiuseppe Lopalco, Maria Morrone, Fabiola Atzeni, et al.
Rheumatology (Oxford, England)|August 4, 2025
Targeting axial and peripheral psoriatic arthritis: a retrospective observational study on the clinical relevance of upadacitinibGiuseppe Lopalco, Eleonora Celletti, Maria Morrone, et al.
Pageof 27